Risk of lymphoma in patients receiving antitumor necrosis factor therapy: A meta-analysis of published randomized controlled studies

Clinical Rheumatology

Volumn 31, Issue 4, 2012, Pages 631-636

  Wong, Anna K ^b   Kerkoutian, Susan ^a   Said, Jonathan ^a   Rashidi, Hooman ^b   Pullarkat, Sheeja T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adalumimab; Etanarcept; Infliximab; Lymphoma; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ADALIMUMAB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE LEUKEMIA; ADULT; ARTICLE; B CELL LYMPHOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; META ANALYSIS; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859763331     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1895-y     Document Type: Article

References (29)

1. Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907-916 (Pubitemid 32224400)
2. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bill H et al (1994) Randomised double blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110 (Pubitemid 24317629)
3. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL et al (1997) Treatment of rheumatoid arthritis with a recombinant human necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147 (Pubitemid 27306284)
4. Salfeld J, Kaymakcalan Z, Tracey D, Roberts A, Kamen R (1998) Generation of fully human anti-TNF antibody D2E7[abstract]. Arthritis Rheum 41(Suppl 9):S57
5. Bare P, Joosten LA, den Broeder AA, van de Putte LB, Van Riel PL, van den Berg WB (2001) Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNF alpha in patients with rheumatoid arthritis. Ann Rheum Dis 60:660-669 (Pubitemid 32588369)
6. Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumors of haematopoietic and lymphoid issues. IARC, Lyon
7. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
8. Lipsky PE, van der Heijde D, Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594-1602 (Pubitemid 32162982)
9. Furst DE, Schiff MH, Fleischmann RM et al (2003) Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 30:2563-2571 (Pubitemid 37549331)
10. Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400-1411 (Pubitemid 38608061)
11. Van de Putte LB, Atkins C, Malaise M et al (2004) Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis 63:508-516 (Pubitemid 38530193)
12. Westhovens R, Yocum D, Han J et al (2006) The safety of infliximab, combined with background treatments among patients with rheumatoid arthritis and various comorbidities. Arthritis Rheum 54:1075-1086 (Pubitemid 43672920)
13. Maini RN, Breedveld FC, Kalden JR et al (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:1552-1563 (Pubitemid 28459913)
14. Van de Putte LB, Rau R, Breedveld FC et al (2003) Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis 62:1168-1177 (Pubitemid 37500622)
15. Weinblatt ME, Keystone EC, Furst DE et al (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35-45, Erratum in Arthritis Rheum. 2003; 48(3):855 (Pubitemid 36091645)
16. St Clair EW, van der Heijde DM, Smolen JS et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50:3432-43 (Pubitemid 39488667)
17. Breedveld FC, Weisman MH, Kavanaugh AF et al (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26-37 (Pubitemid 43122183)
18. Klareskog L, van der Heijde D, de Jagar JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double blind randomized controlled studies. Lancet 363:675-681 (Pubitemid 38296553)
19. Genovese MC, Bathon JM, Martin RW et al (2002) Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 46:1443-1450 (Pubitemid 34620189)
20. Combe B, Codreanu C, Fiocco U et al (2009) Etanercept and sulfasalazine alone and combined in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double blind comparison. Ann Rheum Dis 65:1357-1362 (Pubitemid 44620447)
21. Abe T, Takeuchi T, Miyasaka N et al (2006) A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. J Rheumatol 33:37-44 (Pubitemid 43054277)
22. Ekström K, Hjalgrim H, Brandt L et al (2003) Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 48:963-970 (Pubitemid 36418238)
23. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Møller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 32:1753-1757 (Pubitemid 26306889)
24. Gridley G, McLaughlin JK, Ekbom A et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307-311 (Pubitemid 23068804)
25. Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr (1994) Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120:35-39 (Pubitemid 24011498)
26. Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L (2004) Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 16:254-261 (Pubitemid 38530494)
27. Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etenercept, a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259 (Pubitemid 29063266)
28. Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740-1751 (Pubitemid 38725085)
29. Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 13 (8):1024-1030 (Pubitemid 47309975)